Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration. (2017)
Attributed to:
Structure-function studies on Clostridium difficile large toxins
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/cei.12946
PubMed Identifier: 28213939
Publication URI: http://europepmc.org/abstract/MED/28213939
Type: Journal Article/Review
Volume: 188
Parent Publication: Clinical and experimental immunology
Issue: 3
ISSN: 0009-9104